| The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis ST Wilkinson, ED Ballard, MH Bloch, SJ Mathew, JW Murrough, A Feder, ... American journal of psychiatry 175 (2), 150-158, 2018 | 596 | 2018 |
| Gone to pot–a review of the association between cannabis and psychosis R Radhakrishnan, ST Wilkinson, DC D’Souza Frontiers in psychiatry 5, 72718, 2014 | 467 | 2014 |
| Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) M Fava, MP Freeman, M Flynn, H Judge, BB Hoeppner, C Cusin, ... Molecular psychiatry 25 (7), 1592-1603, 2020 | 327 | 2020 |
| Marijuana legalization: impact on physicians and public health ST Wilkinson, S Yarnell, R Radhakrishnan, SA Ball, DC D'Souza Annual review of medicine 67, 453-466, 2016 | 244 | 2016 |
| Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression—TRANSFORM-3 R Ochs-Ross, EJ Daly, Y Zhang, R Lane, P Lim, RL Morrison, D Hough, ... The American Journal of Geriatric Psychiatry 28 (2), 121-141, 2020 | 208 | 2020 |
| Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2) E Wajs, L Aluisio, R Holder, EJ Daly, R Lane, P Lim, JE George, ... The Journal of clinical psychiatry 81 (3), 10773, 2020 | 196 | 2020 |
| Marijuana use is associated with worse outcomes in symptom severity and violent behavior in patients with posttraumatic stress disorder ST Wilkinson, E Stefanovics, RA Rosenheck The Journal of clinical psychiatry 76 (9), 11266, 2015 | 174 | 2015 |
| 20-year trends in the pharmacologic treatment of bipolar disorder by psychiatrists in outpatient care settings TG Rhee, M Olfson, AA Nierenberg, ST Wilkinson American Journal of Psychiatry 177 (8), 706-715, 2020 | 161 | 2020 |
| Impact of cannabis use on the development of psychotic disorders ST Wilkinson, R Radhakrishnan, DC D’Souza Current addiction reports 1, 115-128, 2014 | 144 | 2014 |
| A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter … ST Wilkinson, G Sanacora Drug discovery today 24 (2), 606-615, 2019 | 141 | 2019 |
| Cognitive behavior therapy may sustain antidepressant effects of intravenous ketamine in treatment-resistant depression ST Wilkinson, DS Wright, MK Fasula, L Fenton, M Griepp, RB Ostroff, ... Psychotherapy and Psychosomatics 86 (3), 162-167, 2017 | 123 | 2017 |
| A survey of the clinical, off-label use of ketamine as a treatment for psychiatric disorders ST Wilkinson, M Toprak, MS Turner, SP Levine, RB Katz, G Sanacora American Journal of Psychiatry 174 (7), 695-696, 2017 | 113 | 2017 |
| A systematic review of the evidence for medical marijuana in psychiatric indications ST Wilkinson, R Radhakrishnan The Journal of clinical psychiatry 77 (8), 11477, 2016 | 101 | 2016 |
| Hippocampal volume changes following electroconvulsive therapy: a systematic review and meta-analysis ST Wilkinson, G Sanacora, MH Bloch Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 2 (4), 327-335, 2017 | 91 | 2017 |
| Identifying recipients of electroconvulsive therapy: data from privately insured Americans ST Wilkinson, E Agbese, DL Leslie, RA Rosenheck Psychiatric services 69 (5), 542-548, 2018 | 90 | 2018 |
| Problems with the medicalization of marijuana ST Wilkinson, DC D’Souza Jama 311 (23), 2377-2378, 2014 | 78 | 2014 |
| Ketamine versus ECT for nonpsychotic treatment-resistant major depression A Anand, SJ Mathew, G Sanacora, JW Murrough, FS Goes, M Altinay, ... New England Journal of Medicine 388 (25), 2315-2325, 2023 | 65 | 2023 |
| Leveraging neuroplasticity to enhance adaptive learning: the potential for synergistic somatic-behavioral treatment combinations to improve clinical outcomes in depression ST Wilkinson, PE Holtzheimer, S Gao, DS Kirwin, RB Price Biological psychiatry 85 (6), 454-465, 2019 | 65 | 2019 |
| Associations of adverse childhood experiences with past‐year DSM‐5 psychiatric and substance use disorders in older adults TG Rhee, LC Barry, GA Kuchel, DC Steffens, ST Wilkinson Journal of the American Geriatrics Society 67 (10), 2085-2093, 2019 | 64 | 2019 |
| Acute and longer-term outcomes using ketamine as a clinical treatment at the Yale Psychiatric Hospital ST Wilkinson, RB Katz, M Toprak, R Webler, RB Ostroff, G Sanacora J Clin Psychiatry 79 (4), 17m11731, 2018 | 64 | 2018 |
